CHRM3 and cancer: The work described above showed overexpression of M3R/CHRM3 in the majority of cancer samples studied and, importantly, revealed that the distribution of expression was altered, shifting from the basolateral membrane in normal tissue to more diffusely along the cell surface in cancer.